Officer sold ~$1.03M of Regeneron Pharmaceuticals
Scheduled in advanceLoading…
Planned for Sep 3, 2026 · Notice filed Sep 3, 2026
A top manager at Regeneron Pharmaceuticals told the SEC they plan to sell $969K of Regeneron Pharmaceuticals shares around Sep 3, 2026. The shares came from their pay, which is the usual reason to sell.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
None found in footnotes
Only flagged when a footnote says so; never inferred
Officer sold ~$1.03M of Regeneron Pharmaceuticals
Scheduled in advanceOfficer sold ~$970K of Regeneron Pharmaceuticals
Scheduled in advanceDerivative exercise or conversion — not an open-market buy.